What is Ledipasvir and its relevance to hepatitis C and potential for COVID-19 treatment?
Label:chem
Topic
Compound: Ledipasvir
Answer
Ledipasvir is a direct-acting antiviral (DAA) used in combinations to treat chronic HCV genotypes 1, 4, 5, and 6. Its mechanism of action is postulated to prevent hyper-phosphorylation of NS5A, essential for viral protein reproduction, RNA replication, and assembly of HCV virions. In this study, it showed a high binding affinity of 9.4 with COVID-19 protease, making it a promising candidate for COVID-19 protease inhibition.
Return to Home
Chemical List
Knowledge you may be interested in